PL3193859T3 - Preparaty do leczenia i zapobiegania czerwienieniu po alkoholu i reakcjom nadwrażliwości wywołanym alkoholem - Google Patents
Preparaty do leczenia i zapobiegania czerwienieniu po alkoholu i reakcjom nadwrażliwości wywołanym alkoholemInfo
- Publication number
- PL3193859T3 PL3193859T3 PL15841584.4T PL15841584T PL3193859T3 PL 3193859 T3 PL3193859 T3 PL 3193859T3 PL 15841584 T PL15841584 T PL 15841584T PL 3193859 T3 PL3193859 T3 PL 3193859T3
- Authority
- PL
- Poland
- Prior art keywords
- alcohol
- rednesses
- preparations
- prevention
- treatment
- Prior art date
Links
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 title 1
- 206010020751 Hypersensitivity Diseases 0.000 title 1
- 208000026935 allergic disease Diseases 0.000 title 1
- 238000006243 chemical reaction Methods 0.000 title 1
- 230000009610 hypersensitivity Effects 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/223—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of alpha-aminoacids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pulmonology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Addiction (AREA)
- Otolaryngology (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Ophthalmology & Optometry (AREA)
- Emergency Medicine (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20145806A FI128082B (en) | 2014-09-15 | 2014-09-15 | Preparations for the treatment and prevention of alcohol redness and alcohol-induced hypersensitivity reactions |
| PCT/FI2015/050612 WO2016042205A1 (en) | 2014-09-15 | 2015-09-15 | Preparations for treatment and prevention of alcohol flushing and alcohol-induced hypersensitivity reactions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3193859T3 true PL3193859T3 (pl) | 2023-11-20 |
Family
ID=55532597
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL15841584.4T PL3193859T3 (pl) | 2014-09-15 | 2015-09-15 | Preparaty do leczenia i zapobiegania czerwienieniu po alkoholu i reakcjom nadwrażliwości wywołanym alkoholem |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20170252312A1 (pl) |
| EP (1) | EP3193859B1 (pl) |
| JP (1) | JP2017527595A (pl) |
| KR (1) | KR20170052688A (pl) |
| CN (1) | CN105434415A (pl) |
| FI (2) | FI128082B (pl) |
| PL (1) | PL3193859T3 (pl) |
| WO (1) | WO2016042205A1 (pl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114144493A (zh) * | 2019-05-23 | 2022-03-04 | Ekyj Ii 咨询有限责任公司 | 治疗和减轻酒精诱导的皮肤潮红的组合物和方法 |
| CN112972395B (zh) * | 2019-12-02 | 2022-12-13 | 湖北舒邦药业有限公司 | 胶囊制剂及其制备方法和应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012027603A2 (en) * | 2010-08-26 | 2012-03-01 | Clarity Products, Limited Liability Company | Therapeutic consumable compositions for reduction of facial flush effect incident to alcohol consumption in persons with deficient activity of the aldehyde dehydrogenase gene-aldh2 |
| EP2589381B1 (en) * | 2011-11-04 | 2016-08-31 | Rabindra Tirouvanziam | Compositions for improving or preserving lung function in a patient with a pulmonary disorder |
| FI129157B (en) * | 2012-05-28 | 2021-08-13 | Biohit Oyj | Composition for use in reducing the incidence of or preventing severe headaches |
| CN102727474A (zh) * | 2012-06-29 | 2012-10-17 | 天津科技大学 | L-半胱氨酸在制备解酒药物、保护肝脏及肾脏药物中的应用 |
| CN110051672A (zh) * | 2012-07-09 | 2019-07-26 | 诺格罗有限责任公司 | 使用膳食补充剂预防酒精反应 |
| WO2014143192A1 (en) * | 2013-03-13 | 2014-09-18 | Noglo Llc | Reduction or prevention of alcohol reaction with dietary supplements |
| US20140256760A1 (en) * | 2012-07-09 | 2014-09-11 | Noglo Llc | Reduction or prevention of alcohol reaction with dietary supplements |
| US20150202181A1 (en) * | 2013-01-23 | 2015-07-23 | Paolo B DePetrillo | Method of and compounds for the reduction of alcoholic hangover |
-
2014
- 2014-09-15 FI FI20145806A patent/FI128082B/en active IP Right Grant
-
2015
- 2015-03-23 CN CN201510126922.1A patent/CN105434415A/zh active Pending
- 2015-09-15 JP JP2017514700A patent/JP2017527595A/ja active Pending
- 2015-09-15 EP EP15841584.4A patent/EP3193859B1/en active Active
- 2015-09-15 FI FIEP15841584.4T patent/FI3193859T3/fi active
- 2015-09-15 WO PCT/FI2015/050612 patent/WO2016042205A1/en not_active Ceased
- 2015-09-15 PL PL15841584.4T patent/PL3193859T3/pl unknown
- 2015-09-15 US US15/511,126 patent/US20170252312A1/en not_active Abandoned
- 2015-09-15 KR KR1020177010320A patent/KR20170052688A/ko not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP3193859B1 (en) | 2023-07-05 |
| KR20170052688A (ko) | 2017-05-12 |
| EP3193859A1 (en) | 2017-07-26 |
| FI128082B (en) | 2019-09-13 |
| WO2016042205A1 (en) | 2016-03-24 |
| FI20145806A7 (fi) | 2016-03-16 |
| FI20145806A (fi) | 2016-03-16 |
| CN105434415A (zh) | 2016-03-30 |
| EP3193859A4 (en) | 2018-04-18 |
| FI3193859T3 (fi) | 2023-08-07 |
| JP2017527595A (ja) | 2017-09-21 |
| US20170252312A1 (en) | 2017-09-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL283086A (en) | Use of cannabidiol in the treatment of tuberous sclerosis complex | |
| IL258955A (en) | Compositions and methods for treatment of cancer | |
| IL248519A0 (en) | Bioceramic compositions and biomodulatory uses thereof | |
| DK3504187T3 (da) | Anvendelse af pridopidin til behandling af funktionel tilbagegang | |
| PL3265053T3 (pl) | Sposoby leczenia skóry | |
| IL249061B (en) | Combination, composition, and method of administering the combination or composition to animals | |
| PT3142637T (pt) | Formulações e métodos de tratamento de queratina | |
| PT3185957T (pt) | Patisiran para utilização no tratamento de amoloidose mediada por transtirretina | |
| IL258259A (en) | Adjunctive therapy with 25-hydroxyvitamin d and articles therefor | |
| HUE059694T2 (hu) | Készítmény rák kezelésére | |
| HUE061761T2 (hu) | Tetrahidropiranil-amino-pirrolopirimidinon felhasználásra BTK-által közvetített zavarok kezelésében | |
| HUE056287T2 (hu) | Pancreatitis kezelése | |
| IL259861A (en) | Methods and compositions for the treatment of seizure-related disorders | |
| EP3104706A4 (en) | Compositions and methods using the same for treatment of neurodegenerative and mitochondrial disease | |
| DK3481846T3 (da) | 11-substituerede 24-hydroxysteroler til anvendelse til behandling af nmda-relaterede tilstande | |
| BR112016027041A2 (pt) | Combinações farmacêuticas para tratamento do câncer | |
| DK3067075T3 (da) | Vævsendoprotese samt fremgangsmåde til dens fremstilling | |
| EP3182989A4 (en) | Methods and compositions for the prevention and treatment of disease | |
| PL3236960T3 (pl) | Fluralaner do zastosowania w leczeniu demodekozy | |
| IL253983A0 (en) | Compositions and methods of treating fanconi anemia | |
| IL251404B (en) | Substituted aromatic compounds and pharmaceutical compositions for the prevention and treatment of osteoporosis | |
| IL251345B (en) | Compositions for use in the treatment of peri-implantitis | |
| PL3373922T3 (pl) | Kompozycje i sposoby do stosowania do leczenia homocystynurii | |
| DE112015002229A5 (de) | Formulierungen zur Behandlung von Hyperthyreose | |
| PL3429555T3 (pl) | Preparat mesny i jego zastosowanie |